Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.

Abstract excerpt

Acute myeloid leukemia (AML) is a heterogeneous group of disorders characterized by an abnormal proliferation of the myeloid precursors and a maturation block. The most common chromosomal lesions in AML are the t(8;21) and inv(16). To better understand the leukemogenic mechanism of these fusion proteins, we performed gene expression studies in samples from (8;21), AML1 mutated and inv(16) patients, as well as...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Azacitidine
• Share to Core Binding Factor Alpha 2 Subunit